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From 1974 to 1998, 22 isolates of an unusual bacterium, designated as CDC nonoxidizer 1 group (NO-1),
were sent to the Centers for Disease Control and Prevention for identification. The organism's phenotypic
characteristics were similar to asaccharolytic strains of Acinetobacter, but differed in their cellular morphol-
ogy and cellular fatty acid profile. We report here on NO-1's clinical and epidemiologic significance. In all
cases, isolates were recovered from an animal bite wound; 17 (77%) were isolated from a dog bite wound,
4 (18%) from a cat bite wound, and one (5%) from an unspecified animal bite. Clinical data were retrieved
and reviewed for 12 (55%) of the 22 bite victims. None of the patients had preexisting conditions associ-
ated with immunosuppression. Seven (58%) patients were hospitalized for a median stay of 4 days (range
2 to 11 days). The median time between bite to the worsening of symptoms was 17.5 hours (range 3 to 78
hours). All patients recovered following antibiotic treatment.
n estimated  4.4 million animal bites occur each year in
the United States (1,2). The annual incidence of dog and
cat bites has been reported as 300 bites per 100,000 population
(3). The most common organisms isolated from infected dog
and cat bite wounds are Staphylococcus spp., Streptococcus
spp., Corynebacterium spp., anaerobes, and Pasteurella multo-
cida (4,5). 
In December 1974, the Special Bacteriology Reference
Laboratory (SBRL) in the Meningitis and Special Pathogens
Branch, Centers for Disease Control and Prevention (CDC),
received a bacterial isolate recovered from a cutaneous bite
wound of an 8-year-old boy in Texas. The isolate was a
unique, fastidious, non-oxidative, gram-negative rod and was
named nonoxidizer group 1 (NO-1). From 1974 to 1998, the
SBRL identified 21 additional isolates received from state and
local hospital laboratories across the United States and Can-
ada. The biochemical and phenotypic characteristics of the
organism have been described elsewhere (6). However, clini-
cally and epidemiologically relevant data accompanying these
specimens were mostly limited to source of specimen, date of
collection, and occasionally sex and age of the patient. Clinical
course descriptions of patients infected with NO-1 have not
been previously described. To evaluate the significance of this
recently identified group, we conducted a review of clinical
records for patients from whom NO-1 was isolated and sub-
mitted to SBRL for identification between 1974 and 1998.
Methods
Inclusion was limited to those patients from whom isolates
sent to SBRL were identified as NO-1 between 1974 and
1998.  In collaboration with state and territorial public health
epidemiologists and hospital infection control practitioners,
we gathered relevant clinical records and exposure data to
determine the clinical significance of and risk factors for NO-1
infection. State epidemiologists, hospital infection control
practitioners, or both were notified of cases that occurred in
their state or hospital and were requested to submit clinical
records for each case, including chart notes, discharge summa-
ries, and clinical laboratory results. Using a standardized form,
we abstracted clinical data for each patient. Information
recorded included demographic characteristics, signs and
symptoms of illness, treatment, laboratory results, and out-
come. We collected information on symptoms including
erythema, swelling, drainage, cellulitis, loss of motion, and
any other symptoms that treating physicians noted. 
This protocol was determined to be exempt from human
subjects review requirements because the gathering of clinical
information to accompany strains was a standard part of refer-
ence diagnostic submission, and, therefore, considered surveil-
lance activity for a newly emerging pathogen. No specific
research question was investigated.
Data were entered and analyzed with Epi Info version 6.04
(CDC, Atlanta GA). Continuous variables were evaluated by
using the Kruskal-Wallis test, and categorical variables were
compared by using the chi-square test or Fisher’s exact methods.
Results
Of the 22 patients from whom NO-1 isolates were recov-
ered, 11 (50%) were male and the a median age of all patients
was 22 years (range 20 months to 78 years). The median age
of males was significantly different from that of females (9 vs.
25 years, p<0.05). In all 22 cases, the organism was isolated
from an animal bite wound site: 17 (77%) from a dog bite
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wound, 4 (18%) from a cat bite wound, and 1 (5%) with no
recorded bite source.  Fourteen (64%) isolates came from bites
on the extremities, 6 (27%) came from face or neck wounds,
and for 2 (9%) no anatomic site was specified.
We were unable to retrieve 10 (45%) of the 22 medical
records for reasons including 1) records were lost, destroyed
by accident or natural occurrence, or archived off-site, or 2) a
patient was seen in the emergency room and notations were
not in the patient record. The 12 patients whose records were
available for review are summarized in Table 1. Of these
patients, 4 (33%) were male with a median age of 40 years
(range 7 to 61 years). Eight (67%) had dog bite wounds, and
the remaining 4 (33%) had cat bites. Eleven (92%) received
bite wounds on the extremities, including hands, arms, or legs;
one bite occurred on the face. The median time interval from
bite to onset or worsening of symptoms was 17.5 hours (range
3 to 78 hours). Ten patients were afebrile; in two cases, a tem-
perature >38.9°C was recorded. At treatment, 67% of patients
reported increased pain associated with erythema and swelling
around the wound site. Purulent drainage was noted in 50% of
cases, and a diagnosis of cellulitis was made for 67% of
patients. There was no evidence of sepsis, although blood cul-
tures were attempted in only four cases. For those patients for
whom records were retrieved, decreased range of motion was
documented in 4 (36%) of the 11 with extremity wounds.
Other reported symptoms included ecchymosis (8%),
increased local temperature (8%), tingling sensations (8%),
chills (8%), adenitis/lymphadenopathy (25%), and discolora-
tion (25%) including “streaking.” Total leukocyte counts
ranged from 8,100 to 12,700 cells/mm3. Hematocrit (range
36% to 43%) and platelet counts (range 140 to 331 K/mm3)
were normal. Laboratory reports on cultures from wound spec-
imens are summarized in Table 2. Isolates later identified as
NO-1 were originally described as fastidious gram-negative
rods, polymorphic gram-negative rods, or gram-negative
bacilli. Concentrations of NO-1 in these specimens ranged
from light to moderate. Most of the specimens contained mix-
tures of two or more bacterial species, although specimens
from Cases 6 and 11 yielded apparently pure cultures of NO-1.
Other bacterial organisms isolated from these wounds
included  Weeksella zoohelcum,  Eikenella corrodens,  Pas-
teurella multocida, Staphylococcus aureus, and Corynebacte-
rium spp., coagulase-negative Staphylococci, and unidentified
gram-positive cocci and enteric gram-negative rods. None of
the NO-1 isolates were identified by the original hospital labo-
ratory.
Table 1. Characteristics of patients for whom records were available and from whom NO-1 isolates were obtained
Case 
no. State
Gender/
age (yrs) Animal
Wound 
site
No. days 
ill Sutured Major clinical features
Antibiotic 
treatment/outcome
1 MA F/22 Cat Hand 8 Unk. Cellulitis, loss of motion, 
purulent drainage, fever
Improved with cephradine + 
penicillin (OP)  
2 IL M/45 Dog Hand 5 Unk. Purulent drainage, redness and 
swelling extending up to forearm
Cefadroxil (OP); next day admitted to 
hospital and gradual improvement with 
ampicillin/sulbactam (IP) 
3 IL F/11 Dog Hand 6 Yes Cellulitis, purulent drainage, local 
increase in temperature
Improved with ampicillin + ceftriaxone, 
local bacitracin (IP) 
4 RI F/78 Cat Hand 3 Unk. Cellulitis, decreased movement Antibiotic ointment + amoxicillin/cla-
vulanic acid (OP1); penicillin 
(OP2); admitted to hospital next 
evening and gradually improved on 
ampicillin/sulbactam (IP) 
5 SC F/37 Dog Hand 7 Unk. Cellulitis, purulent drainage  Cephradine (OP); admitted to 
hospital and improved on 
gentamicin + ampicillin (IP)  
6 GA M/7 Dog Leg 11 Yes Cellulitis, purulent drainage, fever, 
red streaking, inguinal adenitis, 
chills
Amoxicillin (OP); improved on 
penicillin + cefazolin, changed 
to cephalexin (IP)  
7 MA M/61 Dog Arm Unk. Unk. Superficial laceration 
with streaking
Penicillina (OP)  
8 CA M/35 Dog Hand 3 Yes  Cellulitis, loss of motion Iproved with cefazolin + 
cephradine (OP)  
9 CA F/24 Cat Hand 2 Unk. Cellulitis, purulent drainage, lym-
phadenitis, tingling sensations
Resolved with cefazolin + 
penicillin (IP)   
10 TN F/51 Dog Face 5 Yes Pustule of wound Improved with cephalexin (OP) 
11 NV F/56 Cat Arm Unk. Unk. Swelling, lymphadenopathy Dicloxacillina (OP)
12 MI F/21 Dog Hand 3 Yes Cellulitis, impaired range of 
motion 
Cefaclor (OP) + improved 
with cefazolin (IP)  
Unk. = Unknown; OP = outpatient; OP1 = outpatient visit 1; OP2 = outpatient visit 2; IP = inpatient. 
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No data were available on the depth of the wounds. Stan-
dard cleansing, including irrigation and debridement of
wounds followed by dressing, was documented for 8 of 12
patients. Five of the 12 patients had wound closure by suture
after irrigation. No associations were seen between suture ther-
apy and severity of symptoms or duration of recovery.
Seven (58%) persons were hospitalized for treatment; 5
(42%) were managed as outpatients (Table 1). The 7 hospital-
ized patients had a median stay of 4 days (range 2 to 11 days).
All 12 patients were given one or more antibiotic treatments
within 1 to 3 days of receiving bite wounds. Initial therapy for
patients included at least a beta-lactam antibiotic (Table 1).
Five patients (Cases 2, 4, 5, 6, and 12) were initially treated as
outpatients and were subsequently admitted for worsening of
symptoms. In-hospital treatment for these five patients
included either intravenous beta-lactam or intravenous beta-
lactam with beta-lactamase inhibitor. One patient also received
an aminoglycoside. Eight (67%) of 12 cases, including all 7
inpatients, received intravenous antibiotic therapy. Four of the
five outpatients received oral antibiotics only. However, no
documentation of compliance for these patients was found.
Though most patients were released before infection com-
pletely resolved, all  patients for whom follow-up information
was available had documented improvement of the infection.
Symptoms resolved within 2 to 11 days (median 5.5 days). 
A history of asthmatic bronchitis and respiratory allergies,
arthritis, and a ventricular septal defect was noted for Cases 6,
4, and 9, respectively. Two patients were elderly (>60 years).
No preexisting conditions or illnesses were documented for
the rest of the patients. 
Discussion
NO-1 is a recently identified bacterium associated with
dog and cat bite wounds. Infections in which NO-1 bacteria
were isolated appear to be local (i.e., abscess and cellulitis).
Following receipt of a bite wound, NO-1 infections, without
severe disease, can occur in healthy persons with no underly-
ing illness. The most common clinical features associated with
NO-1 infections included purulent drainage, increased pain
with erythema and swelling, and cellulitis, which are clinically
similar to features of infections caused by other animal bite-
related organisms (5). Apparently pure cultures of NO-1 were
obtained from wound specimens of Cases 6 and 11. Although
Case 11 resolved with outpatient dicloxacillin treatment, Case
6 required hospitalization and multiple antibiotic treatments.
This patient also had symptoms consistent with septicemia
(fever, chills). Taken together, these facts suggest that NO-1
infections can progress from localized to systemic forms. At
this time there is no available information on potential viru-
lence factors for NO-1. 
As described by Hollis et al., the phenotypic characteristics
of NO-1 are similar to those observed with asaccharolytic
Acinetobacter species (6). NO-1 bacteria fail to acidify carbo-
hydrates and are oxidase, indole, and urease negative. Cellular
fatty acids and ubiquinone analysis are useful in differentiating
NO-1 from Acinetobacter species (6). Studies are under way at
the SBRL to determine the taxonomic classification of NO-1.
The patients from whom NO-1 were isolated were success-
fully treated with a variety of antibiotics.  In general, intrave-
nous antibiotics may have an advantage over oral antibiotics in
preventing bacterial infections associated with bite wounds,
including those caused by NO-1, because of more rapid deliv-
ery of drug to affected tissues (7).  Previously reported antimi-
crobial susceptibility testing of 17 of the 22 strains by a
standard broth microdilution method showed all strains to be
susceptible to aminoglycosides, beta-lactam antibiotics, tetra-
cyclines, quinolones, and sulfonamides. Fifty percent were
resistant to trimethoprim. Some of the isolates were noted to
grow poorly in the broth test for the antimicrobial susceptibil-
ity testing, but all control wells had sufficient growth for inter-
pretable results (6). 
Most dog and cat bite wounds in young children occur on
the face, head, and neck; by contrast, the extremities tend to be
injured in young adults and adults (2,8,9). In our study, of the 6
patients who received bite wounds to the face, head, or neck, 4
(67%) were <8 years, 1 (17%) was a 51-year-old woman, and
1 (17%) was of unknown age. Of the 14 victims who received
bite wounds on an extremity, 1 (7%) was <10 years. Across all
ages, 14 (64%) of all 22 isolates came from bite wounds on the
extremities, consistent with the distribution of animal bite
wounds reported in other studies (5,10,11).
In addition to other pathogens that are associated with bite
wounds, such as Staphylococcus  spp.,  Streptococcus  spp.,
Corynebacterium  spp., anaerobes, and Pasteurella multocida,
NO-1 should be considered in the differential diagnosis of
infected bite wounds from cats and dogs. Group NO-1 organisms
Table 2. Description of all bacterial isolates cultured 
from infected wounds
Case no. Bacterial organisms cultured from wound
1 No documentation of culture results in record
2L i g h t   Weeksella zoohelcum; light fastidious 
gram-negative bacillia
3 Few fastidious gram-negative rods;a coagulase-negative 
Staphylococci on subculture only
4 No growth of organisms noted in record
5 Enterics, few gram-positive cocci; some polymorphic 
gram-negative rodsa
6 Light growth of gram-negative bacillia 
7 No documentation of culture results in record
8 Three types of gram-negative rodsa
9 Few unidentified gram-negative rods;a few mixed 
aerobic skin flora
10 Rare Eikenella corrodens; few gram- negative bacillia
11 Moderate growth of gram-negative bacillia
12 Numerous Pasteurella multocida; rare Staphylococcus aureus; 
few gram-negative rods;a numerous Corynebacterium species 
aIdentified as Centers for Disease Control and Prevention group nonoxidizer 
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have been shown to be similar to two isolates from oral and
nasal fluids from dogs called “unidentifiable species no. 4” by
Bailie et al. (12). Likewise, the association of human NO-1
infections with animal bite wounds received from cats and
dogs suggests that these animals are a reservoir for NO-1 bac-
teria.
At present  no surveillance system exists for reporting dog
or cat bite wound-associated infections and, therefore, the inci-
dence of NO-1 isolated from bite wound infections is not
known; however, these 22 reported cases likely represent only
a fraction of the true number of potential NO-1 infections.
Several of the case records noted the gram-negative rods as
possible exogenous contaminants; thus, many more NO-1
infections may be unrecognized and undocumented. The etio-
logic role and the pathogenicity of NO-1 are unclear.
Enhanced awareness of this organism by physicians will
improve our understanding of this new zoonotic infection and
clarify its clinical significance. With over 4 million animal
bites occurring in the United States each year, bacteria associ-
ated with dog and cat bite wounds, including NO-1, are an
important public health problem. 
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